Dehradun-based medtech startup Sunfox Technologies has raised $7 Mn (around ₹67 Cr) in a Series A funding round led by Ashish Kacholia, Lashit Sanghvi, Alchemy Capital, and 3one4 Capital.
The startup will use the fresh capital to expand its portable cardiac diagnostics platform Spandan across India, grow its team, and invest in R&D, clinical evidence, engineering, and new cardiac technologies.
It will also build regulatory, distribution, and commercial capabilities across the US, Europe, and Africa, the startup said in a statement.
Sunfox said it has regulatory approvals in India, Ghana, Kenya, Tanzania, and South Africa, and is pursuing clearances in the US and the European Union.
The fundraise follows a ₹15 Cr (around $1.8 Mn) round led by Venture Catalysts in 2024.
Founded in 2016 by Rajat Jain, Arpit Jain, Sabit Rawat, Nitin Chandola, and Saurabh Badola, Sunfox develops portable and AI-enabled cardiac diagnostic solutions for hospitals, clinics, telemedicine networks, public health programmes, and home-based monitoring.
Its Spandan devices allow users and healthcare workers to record ECGs using a smartphone and share them with doctors for remote interpretation. According to the startup, the platform can flag cardiac patterns requiring urgent attention, helping healthcare teams identify patients who need further assessment or treatment.
Its digital service platform, Spandan One, supports remote ECG reviews, case coordination, and tele-ECG network management. In public health settings, nurses or health workers can record ECGs at primary and community health centres and send them to doctors or cardiologists at district hubs for review.
Sunfox claims around 60,000 Spandan devices have been deployed across India, reaching more than 20,000 villages.
Source link







